FORWARD PHARMA A/S-ADR (FWP) Stock Fundamental Analysis

USA • Nasdaq • NASDAQ:FWP • US34986J2042

1.95 USD
+0.14 (+7.73%)
At close: Dec 27, 2022
1.5 USD
-0.45 (-23.08%)
After Hours: 12/27/2022, 8:27:04 PM
Fundamental Rating

2

Overall FWP gets a fundamental rating of 2 out of 10. We evaluated FWP against 525 industry peers in the Biotechnology industry. FWP has a great financial health rating, but its profitability evaluates not so good. FWP has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • FWP had negative earnings in the past year.
  • FWP had a negative operating cash flow in the past year.
FWP Yearly Net Income VS EBIT VS OCF VS FCFFWP Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 0 200M 400M 600M 800M 1B

1.2 Ratios

  • FWP has negative profitability rations, so we won't be analyzing them here.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
FWP Yearly ROA, ROE, ROICFWP Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 0 200 400 600 800 1K

1.3 Margins

  • FWP does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
FWP Yearly Profit, Operating, Gross MarginsFWP Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 20 40 60 80

More info and screens

8

2. Health

2.1 Basic Checks

  • FWP has more shares outstanding than it did 1 year ago.
  • FWP has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
FWP Yearly Shares OutstandingFWP Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 20M 40M 60M 80M
FWP Yearly Total Debt VS Total AssetsFWP Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 50M 100M 150M

2.2 Solvency

  • FWP has an Altman-Z score of 189.78. This indicates that FWP is financially healthy and has little risk of bankruptcy at the moment.
  • FWP's Altman-Z score of 189.78 is amongst the best of the industry. FWP outperforms 99.84% of its industry peers.
  • There is no outstanding debt for FWP. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 189.78
ROIC/WACCN/A
WACCN/A
FWP Yearly LT Debt VS Equity VS FCFFWP Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 0 200M 400M 600M 800M

2.3 Liquidity

  • FWP has a Current Ratio of 117.44. This indicates that FWP is financially healthy and has no problem in meeting its short term obligations.
  • FWP's Current ratio of 117.44 is amongst the best of the industry. FWP outperforms 100.00% of its industry peers.
  • FWP has a Quick Ratio of 117.44. This indicates that FWP is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 117.44, FWP belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 117.44
Quick Ratio 117.44
FWP Yearly Current Assets VS Current LiabilitesFWP Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 20M 40M 60M 80M 100M

More info and screens

0

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 71.10% over the past year.
EPS 1Y (TTM)71.1%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%79.76%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
FWP Yearly Revenue VS EstimatesFWP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 200M 400M 600M 800M 1B
FWP Yearly EPS VS EstimatesFWP Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 -2 -4 -6 -8

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

  • FWP reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
FWP Price Earnings VS Forward Price EarningsFWP Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
FWP Per share dataFWP EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4 0.6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

  • No dividends for FWP!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

FORWARD PHARMA A/S-ADR / FWP FAQ

Can you provide the ChartMill fundamental rating for FORWARD PHARMA A/S-ADR?

ChartMill assigns a fundamental rating of 3 / 10 to FWP.


Can you provide the valuation status for FORWARD PHARMA A/S-ADR?

ChartMill assigns a valuation rating of 3 / 10 to FORWARD PHARMA A/S-ADR (FWP). This can be considered as Overvalued.


Can you provide the profitability details for FORWARD PHARMA A/S-ADR?

FORWARD PHARMA A/S-ADR (FWP) has a profitability rating of 1 / 10.


Can you provide the financial health for FWP stock?

The financial health rating of FORWARD PHARMA A/S-ADR (FWP) is 8 / 10.